Monday, September 26, 2022 1:22:33 PM
Recent PBLA News
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 07/30/2024 09:30:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/30/2024 08:59:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/03/2024 08:46:53 PM
- Panbela Therapeutics Announces Third Independent Safety Review of Phase 3 ASPIRE Clinical Trial DSMB Recommended Continuation with No Trial Modification • GlobeNewswire Inc. • 06/24/2024 12:00:00 PM
- Panbela Announces Oral Presentation at Digestive Disease Week (DDW): • GlobeNewswire Inc. • 06/10/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/29/2024 11:00:27 AM
- Panbela Provides Business Update and Reports Q1 2024 Financial Results • GlobeNewswire Inc. • 05/15/2024 08:10:39 PM
- Panbela Announces Issuance of New Patent in the US and Canada; Patent is for Claims of a Fixed Dose Combination of Eflornithine and Sulindac • GlobeNewswire Inc. • 05/06/2024 12:00:00 PM
- Panbela to Host First Quarter 2024 Earnings Conference Call on May 15, 2024 • GlobeNewswire Inc. • 05/01/2024 08:15:00 PM
- Acceptance of Eflornithine (DFMO) Abstract for Oral Presentation at Digestive Disease Week • GlobeNewswire Inc. • 04/30/2024 12:00:00 PM
- Form PRER14A - Preliminary Proxy Soliciting materials • Edgar (US Regulatory) • 04/26/2024 08:39:41 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/25/2024 08:36:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/25/2024 08:35:56 PM
- Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities • Edgar (US Regulatory) • 04/25/2024 01:09:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/22/2024 12:02:00 PM
- Panbela Therapeutics Announces Interim Data Analysis for ASPIRE Trial Pushed to Q1 2025 • GlobeNewswire Inc. • 04/22/2024 12:00:00 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 04/18/2024 08:31:22 PM
- Panbela Announces Poster Presentation at American Association for Cancer Research: • GlobeNewswire Inc. • 04/18/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/17/2024 12:36:09 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/17/2024 04:15:36 AM
- Panbela Announces Transfer to OTCQB Market • GlobeNewswire Inc. • 04/16/2024 09:29:11 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/04/2024 08:17:05 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 03/29/2024 09:24:31 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 03/29/2024 09:08:13 PM
FEATURED ELEMENT79 GOLD CORP PROVIDES UPDATE ON CHACHAS COMMUNITY CHARTER AND REVENUE GENERATION, M&A ACTIVITIES • Jul 30, 2024 8:00 AM
Avant Technologies Opens Equity Line with GHS Investments as Company Explores Expansion into Additional Technologies • AVAI • Jul 30, 2024 8:00 AM
INDEXR AI Merges With Moon Equity Holdings Corp. (MONI), Creating a Leading-edge Technology Company • MONI • Jul 29, 2024 9:59 AM
Cannabix Technologies to Deliver Innovative Breath Logix Alcohol Screening Device to Texas, USA • BLOZF • Jul 29, 2024 9:07 AM
BNCM AND DELEX UNVEIL POST-MERGER MANAGEMENT PLANS • BNCM • Jul 29, 2024 9:00 AM
Glidelogic Corp. Announces Revolutionary AI-Generated Content Copyright Protection Solution • GDLG • Jul 26, 2024 12:30 PM